Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.98 USD | +2.31% | +1.53% | -5.92% |
Mar. 06 | Vanda Pharmaceuticals : FDA Rejects Hetlioz Expanded Label | DJ |
Mar. 06 | Vanda Pharmaceuticals Announces FDA Update for Supplemental NDA for HETLIOZ in the Treatment of Insomnia | CI |
- Stock
- Equities
- Stock Vanda Pharmaceuticals Inc. - Nasdaq
- News Vanda Pharmaceuticals Inc.